Description: Izotropic Corporation, a research and development company, commercializes diagnostic products for breast cancer. It develops and commercializes next generation 3D breast CT imaging technology for the earlier detection, diagnosis, and treatment of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.
Home Page: izocorp.com
800 – 15355 24th Avenue
Surrey,
BC
V4A 2H9
Canada
Phone:
833 496 2677
Officers
| Name | Title |
|---|---|
| Dr. John McGraw M.Sc., Ph.D. | Pres, CEO, Member of Advisory Board & Director |
| Ms. Jody Bellefleur CPA, CGA, CPA | Chief Financial Officer |
| Ms. Jaclyn Thast | Operations Mang. & Corp. Sec. |
| Mr. Ali Reza Sodagar | Legal Advisor & Independent Director |
| Mr. Robert Louis Thast | Director & Special Advisor |
| Dr. Younes Achkire Ph.D. | Exec. VP of Product Engineering |
| Dr. Andrew M. Hernandez | Head of Imaging Technology |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 115.8079 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | April |
| Full Time Employees: | 0 |